Unusual Responses to PCSK9 Inhibitors in a Real-world Clinical Cohort

• Bruce A. Warden,
• Monark N. Nakrani,
• Carlota Oleaga,
• Om P. Ganda,
• P. Barton Duell,
• Jonathan Q. Purnell,
• Michael D. Shapiro,
• Sergio Fazioa

Affiliations

Bruce A. Warden

Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon

Monark N. Nakrani

Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon

Carlota Oleaga

Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon

Om P. Ganda

Clinical Research and Adult Diabetes Sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts

P. Barton Duell

Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon

Jonathan Q. Purnell

Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon

Michael D. Shapiro

Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon

Sergio Fazioa

Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon